Atea Pharmaceuticals AVIR Insider Ownership

NASDAQ AVIR
$5.18 -0.02 (-0.38%)
At close: Sep 29, 2026 · 4:00 PM EDT

Insider Holdings by Owner

3.09Mn Shares

Insider Ownership Statistics

as of 30 Sep, 2026
Insider Ownership
11.18%
■0% pp QoQ
Shares Held by Insiders
8.95Mn
filed for Sep 2026
■0.00% QoQ
Shares Outstanding
80.05Mn
80,050,518 shares
Direct Holdings
3.09Mn
Indirect: 5.87Mn
Net Shares Traded (QoQ)
0
no net change in Sep 2026
Insiders Holding Shares
12
with Form 4 holdings on file

Shares Owned by Insiders

Shares held % of outstanding
Latest —
Average ownership —
Peak ownership —

Shares Purchased/Sold by Insiders

Bought Sold
Latest quarter —
Net over range —
Buying quarters —

Insider Ownership Summary

Quarter ending 30 Sep, 2026

AVIR's three largest insider shareholders as of September 29, 2026 are Jean-Pierre Sommadossi (President, Ceo, And Chairman, 5.87Mn shares), Andrea Corcoran (Officer, 823.58K shares), Jean-Pierre Sommadossi (President, Ceo, And Chairman, 767.83K shares).

Form 4 Holdings

Insiders Holding AVIR

Insiders 12
Shares held 3.09Mn
Of outstanding 3.86%
# Insider Position Direct Indirect Total Share of Insiders Last Filed
1 Andrea Corcoran Officer 823,576 0 823,576 26.7% 13 Mar, 2026
2 Jean-Pierre Sommadossi President, Ceo, And Chairman 767,830 0 767,830 24.9% 03 Feb, 2026
3 Franklin M Berger Director 536,097 0 536,097 17.4% 23 Jun, 2026
4 Bruno Lucidi Director 142,350 0 142,350 4.6% 23 Jun, 2026
5 Janet Mj Hammond Chief Development Officer 127,665 0 127,665 4.1% 03 Feb, 2026
6 Bruce Polsky Director 124,806 0 124,806 4.0% 23 Jun, 2026
7 Polly A. Murphy Director 121,745 0 121,745 3.9% 23 Jun, 2026
8 Maria Arantxa Horga Chief Medical Officer 96,086 0 96,086 3.1% 03 Feb, 2026
9 Barbara Gayle Duncan Director 92,350 0 92,350 3.0% 23 Jun, 2026
10 Jerome M. Adams Director 92,350 0 92,350 3.0% 23 Jun, 2026
11 John Vavricka Chief Commercial Officer 82,594 0 82,594 2.7% 03 Feb, 2026
12 Wayne Foster Evp, Chief Accounting Officer 79,329 0 79,329 2.6% 03 Feb, 2026

Each row is that insider’s most recently reported position, from Form 4 filings over the last 60 months — which is why this total does not tie to the quarterly series above, where a quarter counts only the insiders who filed in it. Shares held through a fund or institutional portfolio are counted on the institutional ownership page instead.

Form 4 Filings

280 Insider Transactions

Source SEC Form 4
Latest quarter Sep 2026
Download Data
Date Insider Position Transaction Shares Price Value Shares Held After Ownership
18 Jun, 2026 Arthur S Kirsch Director Acquired A 26,700 $0.00 $0 26,700 Direct
18 Jun, 2026 Howard Berman Director Acquired A 26,700 $0.00 $0 26,700 Direct
18 Jun, 2026 Barbara Gayle Duncan Director Acquired M 29,600 $0.00 $0 92,350 Direct
18 Jun, 2026 Bruno Lucidi Director Acquired M 29,600 $0.00 $0 142,350 Direct
18 Jun, 2026 Franklin M Berger Director Acquired M 29,600 $0.00 $0 536,097 Direct
18 Jun, 2026 Bruce Polsky Director Acquired M 29,600 $0.00 $0 124,806 Direct
18 Jun, 2026 Jerome M. Adams Director Acquired M 29,600 $0.00 $0 92,350 Direct
18 Jun, 2026 Polly A. Murphy Director Acquired M 29,600 $0.00 $0 121,745 Direct
18 Jun, 2026 Barbara Gayle Duncan Director Disposed M 29,600 $0.00 $0 0 Direct
18 Jun, 2026 Bruce Polsky Director Disposed M 29,600 $0.00 $0 0 Direct
18 Jun, 2026 Franklin M Berger Director Disposed M 29,600 $0.00 $0 0 Direct
18 Jun, 2026 Jerome M. Adams Director Disposed M 29,600 $0.00 $0 0 Direct
18 Jun, 2026 Polly A. Murphy Director Disposed M 29,600 $0.00 $0 0 Direct
18 Jun, 2026 Bruno Lucidi Director Disposed M 29,600 $0.00 $0 0 Direct
18 Jun, 2026 Arthur S Kirsch Director Acquired A 37,700 $0.00 $0 37,700 Direct
18 Jun, 2026 Howard Berman Director Acquired A 37,700 $0.00 $0 37,700 Direct
18 Jun, 2026 Bruno Lucidi Director Acquired A 26,700 $0.00 $0 26,700 Direct
18 Jun, 2026 Polly A. Murphy Director Acquired A 26,700 $0.00 $0 26,700 Direct
18 Jun, 2026 Barbara Gayle Duncan Director Acquired A 26,700 $0.00 $0 26,700 Direct
18 Jun, 2026 Bruce Polsky Director Acquired A 26,700 $0.00 $0 26,700 Direct